查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1667932

細胞訊號傳導市場 - 全球產業規模、佔有率、趨勢、機會和預測，按類型、產品、技術、途徑、地區和競爭細分，2020-2030 年預測

Cell Signaling Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Product, By Technology, By Pathway, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球細胞訊號傳導市場價值為 56.2 億美元，預計到 2030 年將達到 88.7 億美元，預測期內複合年成長率為 7.87%。全球細胞訊號傳導市場主要受到慢性病盛行率不斷上升、分子生物學進步以及個人化醫療需求不斷成長的推動。細胞訊號傳導在調節生長、分化和免疫反應等關鍵細胞過程中發揮至關重要的作用，這使其在疾病機制（特別是癌症、糖尿病和神經系統疾病）中至關重要。由於細胞訊號通路對於確定新的治療標靶至關重要，藥物研發的興起和標靶治療的需求進一步推動了市場的發展。高通量篩選、生物標記和診斷工具的技術進步正在提高細胞訊號傳導研究的效率。醫療保健和生命科學研究方面不斷成長的投資也為市場擴張做出了巨大貢獻。

市場概況
預測期 2026-2030
2024 年市場規模 56.2 億美元
2030 年市場規模 88.7 億美元
2025-2030 年複合年成長率 7.87％
成長最快的領域 內分泌訊號
最大的市場 北美洲

主要市場促進因素

慢性病和癌症發生率不斷上升

主要市場挑戰

細胞訊號路徑的複雜性

主要市場趨勢

增加生物技術領域的公共和私人資金

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：顧客之聲

第 5 章：全球細胞訊號市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按類型（內分泌訊號、旁分泌訊號、自分泌訊號及其他）
    • 按產品（消耗品和儀器）
    • 按技術（流式細胞儀、顯微鏡檢查、蛋白質印跡法、ELISA 等）
    • 按通路（AKT 訊息傳遞路徑、AMPK 訊息傳遞路徑、ErbB/HER 訊息傳遞路徑等）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第 6 章：北美細胞訊號市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 加拿大
    • 墨西哥

第 7 章：歐洲細胞訊號市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章：亞太地區細胞訊號市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲細胞訊號市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲細胞訊號市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如果有）
  • 最新動態

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章：競爭格局

  • Thermo Fisher Scientific, Inc.
  • QIAGEN NV
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Cell Signaling Technology, Inc.
  • Danaher Corporation
  • Merck KGaA
  • PerkinElmer, Inc.
  • Promega Corporation

第 15 章：策略建議

第16章 關於出版商,免責事項

簡介目錄
Product Code: 27675

Global Cell Signaling Market was valued at USD 5.62 Billion in 2024 and is expected to reach USD 8.87 Billion by 2030 with a CAGR of 7.87% during the forecast period. The Global Cell Signaling Market is primarily driven by the increasing prevalence of chronic diseases, advancements in molecular biology, and the growing demand for personalized medicine. Cell signaling plays a crucial role in regulating key cellular processes such as growth, differentiation, and immune response, making it vital in disease mechanisms, particularly cancer, diabetes, and neurological disorders. The rise in drug discovery and the need for targeted therapies are further propelling the market, as cell signaling pathways are pivotal in identifying new therapeutic targets. Technological advancements in high-throughput screening, biomarkers, and diagnostic tools are enhancing the efficiency of cell signaling research. Growing investments in healthcare and life sciences research also contribute significantly to market expansion.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 5.62 Billion
Market Size 2030USD 8.87 Billion
CAGR 2025-20307.87%
Fastest Growing SegmentEndocrine Signaling
Largest MarketNorth America

Key Market Drivers

Increasing Prevalence of Chronic Diseases and Cancer

Chronic diseases, including cancer, cardiovascular diseases, diabetes, and neurological disorders, have become a major public health concern worldwide. Cancer alone has led to an exponential increase in demand for targeted therapies that specifically influence cell signaling pathways. Cell signaling mechanisms are crucial in both the initiation and progression of cancer. As cancer cells exploit these pathways to grow uncontrollably, therapies targeting these signaling mechanisms are rapidly being developed. According to WHO, in 2021, noncommunicable diseases (NCDs) were responsible for at least 43 million deaths, accounting for 75% of all non-pandemic-related deaths globally. Among these, 18 million individuals died from an NCD before reaching 70 years of age, with 82% of these premature deaths occurring in low- and middle-income countries. Overall, 73% of all NCD-related deaths took place in these regions. Cardiovascular diseases were the leading cause, responsible for at least 19 million deaths in 2021, followed by cancers (10 million), chronic respiratory diseases (4 million), and diabetes (over 2 million, including kidney disease deaths related to diabetes). Together, these four disease categories contribute to 80% of all premature NCD deaths. Risk factors such as tobacco use, physical inactivity, excessive alcohol consumption, unhealthy diets, and air pollution significantly increase the likelihood of dying from an NCD.

Key Market Challenges

Complexity of Cell Signaling Pathways

Cell signaling pathways are highly complex and involve numerous molecules, receptors, enzymes, and transcription factors that interact with each other in a precise and sometimes unpredictable manner. This complexity makes understanding the exact mechanisms behind cellular responses to stimuli challenging. Researchers are often confronted with difficulties in fully mapping out the networks of signaling pathways in different cell types and under varying physiological conditions. There is a lack of comprehensive tools and technologies capable of capturing all the intricacies of these networks. This complexity can delay the identification of key therapeutic targets and make drug discovery more difficult, particularly in diseases with dysregulated signaling. Targeting specific pathways without unintended consequences to other cellular processes is a major concern, increasing the risk of off-target effects. As a result, this complexity can slow the development of effective treatments based on cell signaling and hinder the overall market growth.

Key Market Trends

Increasing Public and Private Funding in Biotechnology

The biotechnology sector is witnessing a significant surge in public and private funding, which directly impacts the cell signaling market. Governments worldwide are investing in healthcare innovation through grants, subsidies, and tax incentives for biotechnology companies that focus on molecular and cellular therapies. Private sector investment, particularly from venture capital firms, is also growing as investors recognize the potential of cell signaling as a therapeutic target. These investments not only support basic research but also stimulate the development of new drug candidates, biologics, and diagnostic tools that leverage knowledge of cell signaling pathways. The increased funding enables the development of cutting-edge research centers and the commercialization of novel products, accelerating market growth.

Key Market Players

  • Thermo Fisher Scientific, Inc.
  • QIAGEN N.V.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Cell Signaling Technology, Inc.
  • Danaher Corporation
  • Merck KGaA
  • PerkinElmer, Inc.
  • Promega Corporation

Report Scope:

In this report, the Global Cell Signaling Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Signaling Market, By Type:

  • Endocrine Signaling
  • Paracrine Signaling
  • Autocrine Signaling
  • Others

Cell Signaling Market, By Product:

  • Consumables
  • Instruments

Cell Signaling Market, By Technology:

  • Flow Cytometry
  • Microscopy
  • Western Blotting
  • ELISA
  • Others

Cell Signaling Market, By Pathway:

  • AKT Signaling Pathway
  • AMPK Signaling Pathway
  • ErbB/HER Signaling Pathway
  • Others

Cell Signaling Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell Signaling Market.

Available Customizations:

Global Cell Signaling market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Signaling Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, and Others)
    • 5.2.2. By Product (Consumables and Instruments)
    • 5.2.3. By Technology (Flow Cytometry, Microscopy, Western Blotting, ELISA, and Others)
    • 5.2.4. By Pathway (AKT Signaling Pathway, AMPK Signaling Pathway, ErbB/HER Signaling Pathway, and Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America Cell Signaling Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Product
    • 6.2.3. By Technology
    • 6.2.4. By Pathway
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cell Signaling Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By Technology
        • 6.3.1.2.4. By Pathway
    • 6.3.2. Canada Cell Signaling Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By Technology
        • 6.3.2.2.4. By Pathway
    • 6.3.3. Mexico Cell Signaling Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By Technology
        • 6.3.3.2.4. By Pathway

7. Europe Cell Signaling Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Product
    • 7.2.3. By Technology
    • 7.2.4. By Pathway
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cell Signaling Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Technology
        • 7.3.1.2.4. By Pathway
    • 7.3.2. United Kingdom Cell Signaling Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Technology
        • 7.3.2.2.4. By Pathway
    • 7.3.3. Italy Cell Signaling Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Technology
        • 7.3.3.2.4. By Pathway
    • 7.3.4. France Cell Signaling Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By Technology
        • 7.3.4.2.4. By Pathway
    • 7.3.5. Spain Cell Signaling Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By Technology
        • 7.3.5.2.4. By Pathway

8. Asia-Pacific Cell Signaling Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Product
    • 8.2.3. By Technology
    • 8.2.4. By Pathway
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Cell Signaling Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Technology
        • 8.3.1.2.4. By Pathway
    • 8.3.2. India Cell Signaling Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Technology
        • 8.3.2.2.4. By Pathway
    • 8.3.3. Japan Cell Signaling Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Technology
        • 8.3.3.2.4. By Pathway
    • 8.3.4. South Korea Cell Signaling Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By Technology
        • 8.3.4.2.4. By Pathway
    • 8.3.5. Australia Cell Signaling Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By Technology
        • 8.3.5.2.4. By Pathway

9. South America Cell Signaling Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Product
    • 9.2.3. By Technology
    • 9.2.4. By Pathway
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Cell Signaling Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Technology
        • 9.3.1.2.4. By Pathway
    • 9.3.2. Argentina Cell Signaling Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Technology
        • 9.3.2.2.4. By Pathway
    • 9.3.3. Colombia Cell Signaling Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Technology
        • 9.3.3.2.4. By Pathway

10. Middle East and Africa Cell Signaling Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Product
    • 10.2.3. By Technology
    • 10.2.4. By Pathway
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Cell Signaling Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Technology
        • 10.3.1.2.4. By Pathway
    • 10.3.2. Saudi Arabia Cell Signaling Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Technology
        • 10.3.2.2.4. By Pathway
    • 10.3.3. UAE Cell Signaling Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Technology
        • 10.3.3.2.4. By Pathway

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Thermo Fisher Scientific, Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. QIAGEN N.V.
  • 14.3. Becton, Dickinson and Company
  • 14.4. Bio-Rad Laboratories, Inc.
  • 14.5. Bio-Techne Corporation
  • 14.6. Cell Signaling Technology, Inc.
  • 14.7. Danaher Corporation
  • 14.8. Merck KGaA
  • 14.9. PerkinElmer, Inc.
  • 14.10. Promega Corporation

15. Strategic Recommendations

16. About Us & Disclaimer